Experience

Shareholder Physician

Hematology Oncology Associates — Medford, OR

Jul 2020 – Present

Community Oncologist and shareholder at physician-owned large practice covering Southern Oregon and Northern California
Training DNP and PA students
Chair of Cancer Committee

Education & Training

Hematology Oncology Fellowship

Medical University of South Carolina — Charleston, SC

Jul 2017 – Jun 2020

Internal Medicine Residency

Medical University of South Carolina — Charleston, SC

Jul 2014 – Jun 2017

Internal Medicine Preliminary Year

American University of Beirut — Beirut, Lebanon

Aug 2013 – Jun 2014

Medical School, M.D. Degree

American University of Beirut — Beirut, Lebanon

Jun 2006 – May 2013

Publications

Publication 1

Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19

Bakouny Z, Labaki C, Grover P, Awosika J, Matar S, Hsu C-Y, et al.

JAMA Oncol. 2023;9(1):128-134

Publication 2

Pegfilgrastim 6 mg versus 12 mg for Autologous Stem Cell Mobilization in Multiple Myeloma Patients: Efficacy, Safety, and Cost Analysis

Matar S, Dany M, Chhabra S, Costa L, Stuart R.

Blood. 2015;126:4306-4306

Publication 3

Advances in immunotherapy for melanoma management

Dany M, Nganga R, Chidiac A, Hanna E, Matar S, Elston D.

Hum Vaccin Immunother. 2016 Oct 2;12(10):2501-2511. PMID: 27454404

Publication 4

mTORC2-Akt signaling axis is implicated in myocardial compensation and fibrosis

Dany M, Rimmani HH, Matar SA, Hajj Hussein I.

J Biol Regul Homeost Agents. 2015 Oct-Dec;29(4):745-53. PMID: 26753634

Publication 5

Parvovirus B19-induced Hemophagocytic Lymphohistocytosis: Case Report and Review of the Literature

Kalmuk J, Matar S, Feng G, Kilb E, Lim MY.

Clin Case Rep. 2019 Sep 27;7(11):2076-2081. PMID: 31788255

Collaborative Research — The Lancet

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

Matar S et al. (CCC19 Consortium)

Lancet. 2020 Jun 20;395(10241):1907-1918. PMID: 32473681

Grants, Awards & Honors

Principal Investigator — $50,000 American Cancer Society grant studying social determinants of health in the local oncology patient population (2024–ongoing)

Ongoing funding via industry-sponsored and cooperative group clinical trials (sub-investigator)
Alpha Omega Alpha Medical Honor Society
First Prize for Outstanding Research, Department of Medicine Research Symposium, MUSC
FDA Scholarship Award for Fellows Day Workshop
Best Resident Scholar Award, chosen by peers, MUSC

Conference Presentations

Panelist, Northwest Women's Cancer Conference, Portland OR, Sept 2022 and Sept 2025
Panelist and presenter, OHSU Knight Cancer Symposium, April 2024
Presenter, American Society of Hematology (ASH)
Presenter, Society of Hematologic Oncology (SOHO)
Pegfilgrastim 6 mg versus 12 mg for Autologous Stem Cell Mobilization in Multiple Myeloma Patients, ASH 2015
Patient Safety Indicators at the American College of Medical Quality, MUSC 2018
My Sick Thyroid Got Me Weak in the Knees, Society of General Internal Medicine 2016
"Doc, fix me. I am swelling up like a balloon!": A Bewildering Case of Anasarca, ACP 2015
Pulmonary Veno-Occlusive Disease (PVOD), ACP 2014
How to prepare for USMLE and apply to the MATCH, Guest Speaker, AUB 2014
Molecular genetic analysis in a Lebanese family with AVNRT, Research Day at AUB 2013